Globally, the gastric cancer therapeutics is growing due to high prevalence rates of gastric

The main goal of gastric cancer therapeutics is to treat the disease. The most common treatment is a surgical resection of the stomach. Surgery is performed when the tumor is too large to be removed through surgery. In some cases, other forms of cancer treatment are needed. In some cases, radiation therapy is the only option. However, there are some other treatments that are worth considering. In some cases, it may be better to have a combination of both.

The most common gastric cancer therapeutics are chemoradiotherapy and surgery. Surgery is the primary method for resection of the tumor. In the majority of cases, patients with this type of cancer can expect a five-year survival rate of 20-25%. Combined modality strategies increase survival rates to 30-35%. Although preoperative chemotherapy does not improve survival, it is highly recommended for early-stage gastric cancer. After chemoradiotherapy, surgery is the most common treatment for GC. While it is still the primary method of treatment, surgical tumor resection is still the most effective. However, patients may experience poorer outcomes when chemoradiotherapy is used prior to surgery. Surgical treatments are associated with more complications than radiation therapy. Some surgical techniques may result in a relapse of the disease, making surgery more difficult.

Patients with GC may undergo a variety of treatment options. Surgical resection is still the primary treatment for GC, and patients usually have a five-year survival rate of twenty to twenty percent. Additionally, combined modality strategies result in 5-year survival rates of thirty to 35 percent. Moreover, preoperative chemo/radiotherapy is largely ineffective. Only 20%-30% of patients achieve a pathologic complete response.

Surgical procedures are the most common part gastric cancer therapeutics. Total or subtotal gastrectomy is a surgical procedure that removes the entire stomach. The cancer may also spread to nearby organs. Postsurgical chemotherapy can improve the chances of survival and help patients tolerate the surgery. Further, chemoradiation may be used to treat the pain associated with recurrent cancer. In most cases, surgery is the only option to treat GC. It offers the only cure. The three most common procedures are total gastrectomy and distal gastrectomy. A resection based on these criteria can improve the patient's chances of obtaining clear microscopic margins. In more severe cases, chemotherapy is the only treatment that can be done after surgery. Once the surgeon has performed the procedure, the patient can continue with the chemotherapy.

Read more @ https://tradove.com/blog/Gastric-Cancer-Therapeutics-Industry-Is-Growing-With-Increasing-Prevalence-Of-Gastric-Cancer-Across-The-World.html